Biomedical AI

One Agent Is a Bottleneck: When Genomics QA Finally Went Multi-Agent Databases are where elegant AI demos go to develop a limp. A model can sound fluent about biology, medicine, finance, or law. Then someone asks a question that requires the latest record from a specialized database, a second lookup from another source, a formatted API call, a large HTML response, and a final answer that does not forget the original question halfway through. Suddenly the “AI assistant” becomes a very expensive intern copying URLs into the wrong field. ...

Handoffs are where promising projects quietly become expensive. A biologist identifies a plausible target. A chemistry team designs a molecule that appears to bind it. Weeks later, pharmacology discovers that the molecule is poorly absorbed, rapidly cleared, or inconveniently toxic. The result travels back upstream as a report, perhaps accompanied by a meeting, several caveats, and the medicinal-chemistry equivalent of “please try again.” ...

Lab meeting. The principal investigator cuts the validation budget from $15,000 to $5,000. The postdoc has already discussed the original plan with an AI research co-pilot. The agent previously suggested a 10-marker flow cytometry panel, bulk RNA-seq validation, and immunofluorescence. Now the researcher returns and says: we need to prioritize. A useful co-pilot should not simply repeat the original protocol with a smaller price tag. It should remember the hypothesis, preserve the scientific goal, understand the new constraint, propose a cheaper validation path, and know which evidence can be deferred without making the proposal look scientifically flimsy. In other words, it must behave less like a brilliant autocomplete box and more like a collaborator with a working memory, a sense of context, and a modest respect for reality. A rare feature, apparently. ...

A laboratory is not a spreadsheet with a sink. That is the small but expensive fact many AI-for-science stories politely step around. Models can rank genes, design proteins, summarise papers, draft protocols, and produce the usual confident parade of mechanistic hypotheses. Then a human still has to seed the cells, choose the pipette, avoid contaminating the plate, notice that an incubation step was skipped, and remember the trick that never made it into the protocol because, apparently, civilisation runs on tacit knowledge and Post-it notes. ...

TL;DR for operators STELLA is not interesting because it calls itself a “self-evolving scientist”. The internet has suffered enough from ambitious nouns. It is interesting because it attacks a real operational bottleneck in biomedical research: the best answer often requires not just reasoning, but finding the right database, building the right analysis environment, running code, checking intermediate results, and deciding when the current workflow is inadequate. ...